drugset / Trial / NCT03825016

Lidocaine Infusion in Hystroscopy

NCT03825016

Phase 2 Completed 44 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Lidocaine infusion in hystroscopic media versus oral diclofenac

Timeline

Start
2017-08-01
Primary completion
2020-01-10
Completion
2020-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified Oral
Subject Lidocaine Other / unclassified Other

Indications

No indication recorded.